In a move to ease a nationwide shortage of infant formula, the Food and Drug Administration on Monday said it has agreed with Abbott Nutrition on a plan to reopen the company’s manufacturing plant in Sturgis, Michigan, after it was shut down following the discovery of a deadly bacteria inside.
The FDA also announced Monday it would make it easier for global manufacturers to sell their product inside the U.S. so long as they meet certain criteria.
